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ABSTRACT
Objective: Tuberculosis (TB) is a highly prevalent infectious disease caused by Mycobacterium tuberculosis. The recommended TB treatment is a 
combination of various antibiotics in the form of a fixed-dose combination tablet or kombipak; however, this increases the prevalence of drug-related 
problems. Therefore, this study aimed to identify drug-related problems of patients receiving TB therapy at the Tebet Subdistrict Health Center from 
July 2018 to December 2018.
Methods: The study was designed as a cross-sectional study using the retrospective data retrieval method from prescriptions of patients with 
TB from July 2018 to December 2018. The classification system prepared by Cipolle, Strand, and Morley was used for the classification of drug-
related problems; this system includes unnecessary drug therapy, required additional drug therapy, ineffective drug, dosage error, and drug 
interaction.
Results: The percentage of unnecessary drug therapy, required additional drug therapy, ineffective drug, dosage error, and drug interaction was 
2.85%, 6.89%, 1.54%, 12.46%, and 66.18%, respectively, with the occurrence of drug-related problems being the highest.
Conclusion: The administration of anti-TB drugs can potentially cause drug-related problems. Therefore, the assessment needs to be optimized 
before the administration of medications to patients and medications should be prescribed and monitored regularly to achieve rational drug use.
Keywords: Tuberculosis, Mycobacterium tuberculosis, Antituberculosis, Drug-related problems, Cipolle.
INTRODUCTION
Tuberculosis (TB) is a highly prevalent communicable disease caused 
by Mycobacterium tuberculosis [1]. The World Health Organization [2] 
stated that 9 million individuals were infected by M. tuberculosis in 
2013 worldwide. Moreover, 1.5 million individuals worldwide die due 
to M. tuberculosis infection annually. In 2017, 87% of new TB cases 
occurred in 30 countries and >95% cases of TB-infected individuals in 
developing countries such as India, China, Indonesia, the Philippines, 
Pakistan, Nigeria, Bangladesh, and South Africa [2]. Indonesia, with 
842,000 cases, is the third country with the highest number of cases of 
TB worldwide after India and China [2-5].
The compliance with medication intake in patients infected with 
TB and with other diseases is challenging, leading to multidrug- or 
rifampicin-resistant (RR) TB (Multidrug resistance [MDR]/RR-TB) [4,5]. 
Some reasons for this include failure in dose use, indiscipline, and drug 
interaction with other medicines [6]. Recently, the treatment success 
rate of patients with TB has decreased from 89.5% in 2008 to 85.1% 
in 2017 [7]. Furthermore, although drug interaction can occur, the 
combination drug therapy is still effective in treating TB [8]. Problems 
mentioned earlier are part of the problems observed in treating 
patients with TB [2,9,10].
Problems related to drug resistance can possibly occur or can potentially 
become a problem in treatment. Moreover, it can influence quality of 
life and affect the socioeconomic status of patients. To date, there have 
been many issues in the management of patients with MDR/RR-TB 
related to indication, efficacy, safety, and discipline [11,12]. Therefore, 
pharmacists have an important role in providing drug rationally to 
patients to tackle and reduce problems [13].
Successful treatment of patients with TB can be achieved by complex 
treatment with long-term duration. This study aimed to analyze and 
identify anti-TB drug-related problems at the Tebet Subdistrict Health 
Center in 2018.
METHODS
This study used cross-sectional, descriptive, and secondary data 
analysis from adult prescription medicine from July 2018 to December 
2018 at the Tebet Subdistrict Health Center. The study was conducted 
from February 2019 to July 2019. The study has received a research 
permit from Unit Pelaksana Pelayanan Terpadu Satu Pintu, Kota 
Administrasi Jakarta Selatan by number 237/082.61.
The samples of this study were randomly selected from the prescription 
of patients with TB aged 18–64 years. The diagnosis was coded using 
the International Classification of Diseases-10 (ICD-10). ICD-10 A15.0 
indicates patients with TB confirmed by sputum microscopic test with 
or without sputum culture, ICD-10 A15.1 indicates patients with TB 
diagnosed only by sputum culture, ICD-10 A15.2 indicates patients with 
TB confirmed by histologic examination, and ICD-10 A15.3 indicates 
patients with TB diagnosed by unpredictable test. Exclusion criteria 
were incomplete prescriptions, prescription for MDR/RR-TB, pregnant 
women with TB, patients with HIV, patients with TB, TB with more than 
one code of ICD-10, and respiratory TB.
Data were analyzed using univariate analysis using Microsoft Excel 2013. 
Analysis was performed to examine the incidence distribution related 
to drug problems of patients with TB classified by Cipolle et al. [14]. 
Furthermore, the data used to analyze the percentage of problems 
related to medicine and medicine interaction caused from drug therapy 
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using online IBM Micromedex Web Access Application and/or Drug 
Interaction Checker Medscape.
RESULTS
The total sample was 2023 prescriptions. However, only 483 
prescriptions were included in the final analysis. Other prescriptions 
were excluded because they did not meet the inclusion criteria. 
Tables 1 and 2 summarize patient characteristics.
The result showed that the TB status in men at 62.41% was higher than 
that in women. Based on age, patients with TB were aged 18-<36 years. 
Table 2 shows characteristics of patient with TB based on age.
Table 3 shows the description of prescriptions.
The problem identification of this study used the classification 
system from Cipolle et al. [14]. The classification consisted of seven 
classifications, such as treatment requiring other additional medicines, 
unnecessary prescription of drugs, overdose, less dose, wrong medicine, 
unwanted drug reaction, and patient compliance [14]. Table 4 shows 




In this study, the number of male patients with TB was more than that 
of women. First, this may be due to the patriarchal culture in Indonesia, 
where men can generally access TB treatment more easily [15]. Second, 
more men smoke and consume alcohol compared with women. Higher 
male mobility also increases men’s risk for being more exposed to 
TB-causing bacteria [15]. Women’s immunity to TB is higher than in 
men [16]. Third, the biological microbiological examination of sputum 
in men is more sensitive than that in women; hence, the detection of TB 
in men is easier [17].
TB is highly prevalent in the 18–<36 years of age group. This may be 
due to the high mobility of the reproductive age, and a dense work 
environment causes a patient with TB to potentially transmit the 
disease to his colleagues [15]. In addition, TB can develop potentially 
more in the reproductive age compared with latent TB [18].
Anti-TB drugs are the most prescribed drugs in TB therapy. This 
condition is in accordance with the treatment needed, namely, TB 
therapy with anti-TB drug in the form of fixed dose combination (FDC) 
and kombipak.
Identification of drug-related problems
Unnecessary drug therapy
Drug therapy is unnecessary when the patient has no clinical indication. 
Providing unnecessary therapy can cause resistance, particularly in 
Table 1: Characteristics of patient with tuberculosis based on sex
Sex Total patients (n=133) Percentage
Male 83 62.41
Female 50 37.59
Table 3: Prescription conditions of patients with TB
Name of drug Frequency 
(n=843)
Percentage
Anti-TB drugs 529 62.75
FDC 270 32.03
Anti-TB drug Category 1 232 27.52
Anti-TB drug Category 2 37 4.39







Streptomycin sulfate 138 16.37
Other than anti-TB drugs 314 37.25
FDC: Fixed-dose combination, TB: Tuberculosis
Table 4: Description of drug problems




With drug-related problems 383 79.30
Without drug-related problems 96 19.70
Table 5: Description of unnecessary drug therapy
Drug therapy Recipe sheet (n=843) Percentage
Drug therapy is not needed 24 2.85
Drug therapy is needed 819 97.15
Table 6: Prescription conditions of patients with tuberculosis




Need for additional therapy 33 6,89
No need for additional therapy 446 93,11















13 1.54 9 1.88
Effective drug 843 98,46 470 98.12
Table 8: Description of the accuracy of tuberculosis therapy 
doses at the Tebet Subdistrict Health Center











Accuracy of dosing 738 87.54 391 81.63
Inappropriate dose 105 12.46 88 18.37
Overdose 46 5.46
Low dose 59 7.00
Table 9: Description of potential drug interactions in 
tuberculosis therapy at the Tebet Subdistrict Health Center
Interaction Recipe sheet (n=479) Percentage
With interaction 317 66.18
No interaction 162 33.82
Table 2: Characteristics of patients with tuberculosis based on age
Group of age Number (n=133) Percentage
Group 1 (18–<36 years) 76 57.14
Group 2 (36–<56 years) 37 27.82
Group 3 (56–<65 years) 20 15.04
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prescribing antibiotics. In addition, the administration of unnecessary 
therapy can also cause undesirable effects. The administration 
of unnecessary drug therapy is due to physicians focusing on the 
symptoms of the patient, not based on diagnosis. In addition, demands 
from patients who desire that their symptoms disappear quickly 
encourage doctors to prescribe medications to treat symptoms.
In TB therapy, side effects are nausea, vomiting, and epigastric pain; 
increased liver enzyme levels; arthralgia; acne; and cutaneous pruritus 
or fever [8]. Therefore, in addition to anti-TB drug, additional drugs 
are also prescribed that are intended to overcome the side effects of 
TB therapy. Prescribing loratadine, cetirizine, and chlorpheniramine 
maleate are intended to overcome the side effects of pruritus or itching 
and rashes. Domperidone, ranitidine, omeprazole, and antacids are 
prescribed to overcome the side effects of nausea and vomiting.
Required additional therapeutic drugs
Additional therapeutic drugs are required to prevent the occurrence of 
a clinical condition or disease and to administer initial therapy for a 
medical condition. Additional drug therapy required in this study is the 
provision of anti-TB drug in the form of injection, FDC, or kombipak. 
Prescriptions considered to require additional therapeutic drugs are 
those that only relieve TB symptoms but do not treat TB bacterial 
infections; for example, patients are only prescribed guaifenesin and 
Vitamin B or are only prescribed salbutamol without being prescribed 
anti-TB drug in accordance with TB management guidelines. TB therapy 
without antibiotics can result in more severe infections, recurrence, 
and resistance if patients only undergo some TB therapy procedures 
with anti-TB drug.
Ineffective medicine
Ineffective medicine is when the drug administered does not provide the 
expected effect suitable for a medical condition. One of the cases found 
was dexamethasone prescription, wherein the drug was contraindicated 
for patients with TB. Dexamethasone is an anti-inflammatory agent that 
works by inhibiting cytokines and decreasing cellular immunity. With 
decreased immunity, patients with TB become more susceptible to the 
infectious bacteria. In addition, the administration of dexamethasone 
can also eliminate the symptoms of TB so the patient feels healed after 
its administration although the infection still exists if the patient does 
not undergo therapy with anti-TB drug.
Anti-TB drug for the children category was also prescribed for patients 
aged 59 years who weigh 41 kg. This case is considered as ineffective 
drug administration because anti-TB drug for the children category 
is intended for patients aged 0–14 years based on the management 
used at the Tebet Subdistrict Health Center, the National Guidelines 
for TB Control [19]. For these cases, there are other more effective 
drug choices, namely, Category 1 or 2 anti-TB drug intended for adult 
patients weighing at least 30 kg.
Dosage accuracy
Appropriate dosage is the administration of drugs in accordance 
with the dose based on the patient’s body weight and age, as well as 
the frequency of administration based on official management. The 
accuracy of the dose in TB therapy is still a problem because the low 
dose can result in resistance and lead to failure of therapy, whereas it 
can result in poisoning in cases of overdose if the dose reaches toxic 
levels or can even result in death if the dose given reaches the lethal 
dose.
Drug interaction
Drug interactions are conditions, wherein the effects of a drug change with 
the presence of other drugs, herbal medicines, food, drinks, or chemicals 
in the surrounding environment. The effects of drug interactions can be 
dangerous if the reaction increases the toxicity of a drug. Reduced drug 
efficacy is sometimes also as dangerous as increased toxicity.
Most of the interactions that occur in TB management cause 
hepatotoxicity. However, the use of a combination of interacting 
drugs cannot be avoided; hence, liver function must be monitored by 
checking the levels of alanine aminotransferase (ALT) and aspartate 
aminotransferase to prevent hepatotoxicity. A hepatoprotector, such as 
curcumin, can also be prescribed to protect the liver from damage. The 
administration of anti-TB drug can be stopped if the increase in ALT 
levels exceeds thrice the upper limit of normal (ULN), with an increase 
in bilirubin levels, or an increase in the ALT levels exceeds 5 times the 
ULN without increasing the bilirubin level [20].
CONCLUSION
Patients undergoing TB therapy at the Tebet Subdistrict Health Center 
from July 2018 to December 2018 are mostly men in the 18–<36 years 
of age group. The percentage of unnecessary drug therapy and required 
additional therapeutic drugs for TB therapy is 2.85% and 6.89%, 
respectively. Therefore, prescriptions with writing errors should 
be immediately revised and updated in the Puskesmas information 
system so that the data used for further research can actually reflect 
prescription. The diagnosis in the ICD-10 code should be written in 
full in accordance with the patient’s medical condition to provide the 
appropriate therapy in accordance with the diagnosis of the physician.
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